Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis
Publication
, Conference
Smith, PK; Despotis, GJ; Goodnough, LT; Levy, JH; Poston, RS; Short, MA; Weerakkody, GJ; LeNarz, LA
Published in: CIRCULATION
November 23, 2010
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
November 23, 2010
Volume
122
Issue
21
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, P. K., Despotis, G. J., Goodnough, L. T., Levy, J. H., Poston, R. S., Short, M. A., … LeNarz, L. A. (2010). Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis. In CIRCULATION (Vol. 122). LIPPINCOTT WILLIAMS & WILKINS.
Smith, Peter K., George J. Despotis, Lawrence T. Goodnough, Jerrold H. Levy, Robert S. Poston, Mary A. Short, Govinda J. Weerakkody, and Leroy A. LeNarz. “Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis.” In CIRCULATION, Vol. 122. LIPPINCOTT WILLIAMS & WILKINS, 2010.
Smith PK, Despotis GJ, Goodnough LT, Levy JH, Poston RS, Short MA, et al. Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2010.
Smith, Peter K., et al. “Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis.” CIRCULATION, vol. 122, no. 21, LIPPINCOTT WILLIAMS & WILKINS, 2010.
Smith PK, Despotis GJ, Goodnough LT, Levy JH, Poston RS, Short MA, Weerakkody GJ, LeNarz LA. Mortality Benefit with Prasugrel in TRITON-TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2010.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
November 23, 2010
Volume
122
Issue
21
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology